Prognostic Performance of the FLAMB Model in Primary Gastric Diffuse Large B-Cell Lymphoma
British Journal of Hospital Medicine · 2025
DOI: 10.12968/hmed.2025.0232 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Hospital Medicine, 2025. Verfasst von Jianbo Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Stomach Neoplasms. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Aims/Background Primary gastric diffuse large B-cell lymphoma (PG-DLBCL) is a common gastrointestinal malignancy. While rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP)-based regimens have improved survival, reliable prognostic tools remain scarce. The International Prognostic Index (IPI), though validated for nodal DLBCL, shows limited accuracy in PG-DLBCL. To address this, we developed an intelligent prognostic model integrating key clinical variables to optimize individualized risk stratification, particularly for resource-limited clinical settings.
Methods
A retrospective cohort study was conducted at Nanfang Hospital, Southern Medical University, enrolling patients diagnosed with PG-DLBCL between January 2007 and July 2022. Clinical data and survival outcomes were systematically collected. Optimal cut-off values were systematically determined for continuous variables using receiver operating characteristic (ROC) curve analysis. Survival rates were estimated using the Kaplan-Meier method, with survival curves plotted and univariate survival associations assessed using the log-rank test. Multivariable analyses were performed through Cox proportional hazards regression and random forest algorithms. A novel (ferritin, lactate dehydrogenase (LDH), age, monocyte count (mono), β2-microglobulin (β2-MG)) FLAMB prognostic model was constructed by integrating the Cox regression model with random forest classification. Model performance was evaluated by comparing its discriminative accuracy with that of the IPI scoring system.
Results
Statistically significant differences in 5-year survival among PG-DLBCL patients were observed for ferritin, age, mono, LDH, β2-MG, B symptoms, and cell of origin (COO) in univariate survival analysis (p < 0.05). We developed the FLAMB model using five routinely available variables (ferritin, LDH, age, mono, and β2-MG) to enhance risk stratification in PG-DLBCL. Compared to the IPI, FLAMB demonstrated superior discriminative power (C-index: 0.653 vs. 0.637, Δ = 1.6%) and more effectively identified high-risk patients requiring treatment intensification. This enhanced risk stratification was confirmed by a statistically significant log-rank test (p < 0.05). Survival analysis in subgroups of non-germinal center B-cell like (GCB) and B symptoms-negative patients yielded consistent results.
Conclusion
The newly developed FLAMB prognostic model offers more precise prognostic stratification than the IPI for patients with PG-DLBCL. FLAMB comprises five key variables derived from routine laboratory tests and general clinical characteristics, making it readily accessible. This model enables clinicians, particularly in primary care or community hospitals, to efficiently stratify patient risk, assess underlying disease severity, and inform timely treatment planning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
- Department of Hematology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
- Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
ORCID-Profile: Jianbo Liu, Ao Li, Runhui Zheng, Haiying Wu, Yongqiang Wei, Ru Feng
Zitieren
APA
Liu, J., Li, A., Zheng, R., Wu, H., Wei, Y., & Feng, R. (2025). Prognostic Performance of the FLAMB Model in Primary Gastric Diffuse Large B-Cell Lymphoma. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2025.0232
Vancouver
Liu J, Li A, Zheng R, Wu H, Wei Y, Feng R. Prognostic Performance of the FLAMB Model in Primary Gastric Diffuse Large B-Cell Lymphoma. British Journal of Hospital Medicine. 2025. doi:10.12968/hmed.2025.0232
BibTeX
@article{Liu2025,
author = {Liu, Jianbo and Li, Ao and Zheng, Runhui and Wu, Haiying and Wei, Yongqiang and Feng, Ru},
title = {Prognostic Performance of the FLAMB Model in Primary Gastric Diffuse Large B-Cell Lymphoma},
journal = {British Journal of Hospital Medicine},
year = {2025},
doi = {10.12968/hmed.2025.0232}
}
EUVIMED